X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
prostate cancer (3) 3
aged (2) 2
androgen antagonists - administration & dosage (2) 2
humans (2) 2
index medicus (2) 2
male (2) 2
nitriles (2) 2
prostatic neoplasms - drug therapy (2) 2
radiotherapy (2) 2
tosyl compounds (2) 2
abridged index medicus (1) 1
adjuvant (1) 1
adult (1) 1
aged, 80 and over (1) 1
androgen antagonists (1) 1
androgen antagonists - adverse effects (1) 1
anilides (1) 1
anilides - administration & dosage (1) 1
anilides - adverse effects (1) 1
anilides - therapeutic use (1) 1
antigen (1) 1
antineoplastic agents, hormonal - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
cancer (1) 1
cancer therapies (1) 1
carcinoma (1) 1
care and treatment (1) 1
combined modality therapy (1) 1
deprivation therapy (1) 1
disease progression (1) 1
disease-free survival (1) 1
drug administration schedule (1) 1
endocrine therapy (1) 1
eortc (1) 1
feasibility studies (1) 1
flutamide (1) 1
flutamide - adverse effects (1) 1
flutamide - therapeutic use (1) 1
follow-up studies (1) 1
gonadotropin-releasing hormone (1) 1
gonadotropin-releasing hormone - analogs & derivatives (1) 1
goserelin - administration & dosage (1) 1
health aspects (1) 1
heart attacks (1) 1
heart diseases (1) 1
heart diseases - mortality (1) 1
hormonal-therapy (1) 1
intermittent therapy (1) 1
irradiation (1) 1
life sciences (1) 1
management (1) 1
medical treatment (1) 1
medicine, general & internal (1) 1
middle aged (1) 1
mortality (1) 1
nitriles - adverse effects (1) 1
nitriles - therapeutic use (1) 1
phase-iii trial (1) 1
proportional hazards models (1) 1
prostate-specific antigen - blood (1) 1
prostatic neoplasms (1) 1
prostatic neoplasms - mortality (1) 1
prostatic neoplasms - pathology (1) 1
prostatic neoplasms - radiotherapy (1) 1
quality of life (1) 1
quality-of-life (1) 1
radiation therapy (1) 1
radiation-therapy (1) 1
radiotherapy, conformal (1) 1
radiotherapy, conformal - adverse effects (1) 1
randomized-trial (1) 1
suppression (1) 1
tosyl compounds - adverse effects (1) 1
tosyl compounds - therapeutic use (1) 1
treatment failure (1) 1
treatment outcome (1) 1
tumors (1) 1
urology & nephrology (1) 1
usage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2009, Volume 360, Issue 24, pp. 2516 - 2527
A current standard treatment for locally advanced prostate cancer is external-beam radiotherapy combined with 3 years of androgen suppression. Adverse events,... 
PHASE-III TRIAL | DEPRIVATION THERAPY | IRRADIATION | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | EORTC | RANDOMIZED-TRIAL | QUALITY-OF-LIFE | RADIOTHERAPY | RADIATION-THERAPY | ADJUVANT | Anilides - therapeutic use | Prostatic Neoplasms - radiotherapy | Follow-Up Studies | Anilides - adverse effects | Humans | Middle Aged | Male | Gonadotropin-Releasing Hormone - analogs & derivatives | Flutamide - adverse effects | Treatment Failure | Aged, 80 and over | Adult | Flutamide - therapeutic use | Prostatic Neoplasms - drug therapy | Drug Administration Schedule | Proportional Hazards Models | Combined Modality Therapy | Prostatic Neoplasms - mortality | Disease-Free Survival | Tosyl Compounds - adverse effects | Heart Diseases - mortality | Tosyl Compounds - therapeutic use | Quality of Life | Radiotherapy, Conformal - adverse effects | Aged | Androgen Antagonists - administration & dosage | Androgen Antagonists - adverse effects | Nitriles - adverse effects | Nitriles - therapeutic use | Heart attacks | Medical treatment | Mortality | Radiation therapy | Prostate cancer | Cancer therapies | Quality of life | Index Medicus | Abridged Index Medicus | Androgen Antagonists | Anilides | Life Sciences | Prostatic Neoplasms | Flutamide | Heart Diseases | Radiotherapy, Conformal | Gonadotropin-Releasing Hormone | Nitriles | Tosyl Compounds | Cancer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2009, Volume 360, Issue 24, p. 2516
The study aims to compare the efficacy of radiotherapy along with long-term suppression of androgen against radio therapy with short-term androgen suppression... 
Usage | Care and treatment | Radiotherapy | Health aspects | Prostate cancer
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 06/2009, Volume 360, Issue 24, pp. 2516 - 2527
BACKGROUND The combination of radiotherapy plus long-term medical suppression of androgens (>= 2 years) improves overall survival in patients with locally... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.